mRNA technology expanded rapidly after its use in COVID-19 vaccines, with companies like Moderna developing dozens of new mRNA-based products. Supporters see a major breakthrough in medicine, while some scientists raise questions about long-term safety and real-world outcomes. This episode explores differing perspectives on the mRNA platform and how future research and regulation may shape its role in public health.
